cardiology

News

Pfizer drug reduces mortality in patients with fatal heart d...

Pfizer’s heart disease drug, tafamidis, reduces mortality rates in patients, according to the top-line results of a phase 3 trial.

Views & Analysis

SGLT2 inhibitors: an emerging option for cardiologists?

With studies showing potential for SGLT2 inhibitors in heart failure, a study of HCP online conversations reveals cardiologists are still cautious.

News

NHS England okays funding for cholesterol-lowering drug

Lojuxta will be available to patients this year

News

Amgen's Repatha gets EU cardio risk reduction label

But Sanofi/Regeneron could have advantage thanks to price cut and better data

News

EU approves AZ's potential blockbuster hyperkalaemia drug

After manufacturing issues, AstraZeneca hopes for FDA nod soon.

News

Double blow to Amgen with Sanofi's Praluent data and price c...

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of card

Pfizer drug reduces mortality in patients with fatal heart d...

SGLT2 inhibitors: an emerging option for cardiologists?

NHS England okays funding for cholesterol-lowering drug

Amgen's Repatha gets EU cardio risk reduction label

EU approves AZ's potential blockbuster hyperkalaemia drug

Double blow to Amgen with Sanofi's Praluent data and price c...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

cardiology

Editor's Picks